2008
DOI: 10.1002/jps.21079
|View full text |Cite
|
Sign up to set email alerts
|

Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
188
0
9

Year Published

2011
2011
2021
2021

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 409 publications
(203 citation statements)
references
References 117 publications
2
188
0
9
Order By: Relevance
“…Gerekli bölgede etken maddenin toplanabilmesini sağlamaya yetecek kadar süre vücutta kalabilmektedirler. Nanometre boyutlarında büyüklüğe sahip olmaları, zayıf damarlanmanın olduğu bölgelerde birikmelerine olanak sağlamaktadır (27)(28)(29)(30) (36,37). Lipozomlar, ilk olarak 60'ların ortasında tanımlan-mış, fosfolipid bazlı nanoveziküllerdir (38).…”
Section: İlaç Taşiyici Si̇stemler Olarak Nanotaşiyicilarunclassified
“…Gerekli bölgede etken maddenin toplanabilmesini sağlamaya yetecek kadar süre vücutta kalabilmektedirler. Nanometre boyutlarında büyüklüğe sahip olmaları, zayıf damarlanmanın olduğu bölgelerde birikmelerine olanak sağlamaktadır (27)(28)(29)(30) (36,37). Lipozomlar, ilk olarak 60'ların ortasında tanımlan-mış, fosfolipid bazlı nanoveziküllerdir (38).…”
Section: İlaç Taşiyici Si̇stemler Olarak Nanotaşiyicilarunclassified
“…Since the first nanoparticulate drug delivery systems as Liposome proposed in 1974 [21] lead to several breakthrough discoveries by using nanoparticles as drug carriers resulting from cutting-edge researches based on multidisciplinary approaches, many more applications have developed. Several research reports have been published on the applications of nanoparticulate drug delivery systems using various drug entities and polymers and different forms of drug delivery systems.…”
Section: Nanoparticulate Drug Delivery Systemmentioning
confidence: 99%
“…Among all dendrimers, citric acid dendrimers are popular and easy to synthesize. They have been considered as vehicles for different routes of delivery such as oral, Transdermal, ocular, i.v etc (Cheng et al, 2008). Considering the use of dendrimers for drug delivery, it should be noted that they are bio-compatible, non-toxic (Jain et al, 2010).…”
Section: Introductionmentioning
confidence: 99%